Document:

EX-4.2

 Exhibit 4.2 

Execution Version 

MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V. 

as the Issuer, 

MONDELĒZ INTERNATIONAL, INC. 

as the Parent Guarantor 

and 
 DEUTSCHE BANK
TRUST COMPANY AMERICAS 
 as the Trustee 

and 
 DEUTSCHE BANK
TRUST COMPANY AMERICAS 
 as the Paying Agent 

and 
 DEUTSCHE BANK
TRUST COMPANY AMERICAS 
 as the Registrar and Transfer Agent 

SIXTH SUPPLEMENTAL INDENTURE 

DATED AS OF SEPTEMBER 15, 2022 

TO INDENTURE 
 DATED AS
OF OCTOBER 28, 2016 
 Relating To 

$500,000,000 4.250% Notes due 2025 
  

 SIXTH SUPPLEMENTAL INDENTURE 

SIXTH SUPPLEMENTAL INDENTURE, dated as of September 15, 2022 (this “Supplemental Indenture”), by and among Mondelez International
Holdings Netherlands B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of the Netherlands, and having its principal office at Verlengde Poolseweg 34, Bond Towers,
4818 CL, Breda, The Netherlands (hereinafter called the “Company” or the “Issuer”), Mondelēz International, Inc., as guarantor (the “Parent Guarantor”) and Deutsche Bank Trust Company Americas,
a New York banking corporation organized and existing under the laws of the State of New York, as Trustee (hereinafter called the “Trustee”), Deutsche Bank Trust Company Americas, as paying agent (the “Paying
Agent”) and Deutsche Bank Trust Company Americas, as registrar and transfer agent (the “Registrar and Transfer Agent”), to the Base Indenture (as defined below). 

RECITALS 
 WHEREAS, the Company and
the Parent Guarantor have heretofore executed and delivered to the Trustee an Indenture, dated as of October 28, 2016 (the “Base Indenture”), providing for the issuance from time to time of its securities (hereinafter called
the “Securities”) evidencing its unsecured indebtedness, to be issued in one or more series as therein provided; 
 WHEREAS,
pursuant to the terms of the Base Indenture, the Company desires to provide for the establishment of a series of notes to be known as its 4.250% Notes due 2025 (the “Notes”), and the terms, provisions and conditions thereof to be
set forth as provided in the Base Indenture and this Supplemental Indenture (together, the “Indenture”); and 
 WHEREAS, the Company
and the Parent Guarantor have requested that the Trustee execute and deliver this Supplemental Indenture, and all requirements necessary to make this Supplemental Indenture a legal, valid and binding instrument in accordance with its terms, to make
the Notes, when executed by the Company, the legal, valid and binding obligations of the Company and authenticated by the Trustee, and all acts and things necessary have been done and performed to make this Supplemental Indenture enforceable in
accordance with its terms, and the execution and delivery of this Supplemental Indenture has been duly authorized in all respects. 

WITNESSETH: 
 NOW, THEREFORE, for
and in consideration of the premises contained herein, each party agrees for the benefit of each other party and for the equal and ratable benefit of the Holders of the Notes, as follows: 

ARTICLE ONE 

DEFINITIONS 
 Section 1.01.
Capitalized terms used but not defined in this Supplemental Indenture shall have the meanings ascribed to them in the Base Indenture. 

  
 2 

 Section 1.02. References in this Supplemental Indenture to article and section numbers shall be deemed
to be references to article and section numbers of this Supplemental Indenture unless otherwise specified. 
 Section 1.03. For purposes of this
Supplemental Indenture, the following terms have the meanings ascribed to them as follows: 
 “Base Indenture” has the meaning provided in
the recitals. 
 “Company” or “Issuer” has the meaning provided in the preamble. 

“Designated Agents” means the Persons named as the Paying Agent and the Registrar and Transfer Agent in the preamble and their respective
successors and assigns. 
 “Global Note(s)” means one or more permanent, registered securities in global form. 

“Indenture” has the meaning provided in the recitals. 

“Notes” has the meaning provided in the recitals. For the avoidance of doubt, “Notes” shall include the additional Notes, if any.

 “Parent Guarantor” has the meaning provided in the preamble. 

“Securities” has the meaning provided in the recitals. 

“Shortfall” has the meaning provided in Section 5.03 hereof. 

“Supplemental Indenture” has the meaning provided in the preamble. 

“Trustee” has the meaning provided in the preamble. 

ARTICLE TWO 

GENERAL TERMS AND CONDITIONS OF THE NOTES 

Section 2.01. Designation and Principal Amount. 

(a) Title and Initial Aggregate Principal Amount. The Notes are hereby authorized and are designated the “4.250% Notes due 2025.” The Notes
issued on the date hereof shall initially be limited to an aggregate principal amount of $500,000,000. The Notes shall initially be represented by one or more fully registered Global Notes. 

(b) Additional Notes. Without the consent of the holders of any series of Notes, the Company may issue, from time to time in accordance with the
provisions of the Indenture, additional Notes having the same ranking and the same interest rate, maturity and other terms as such series of Notes (except for the issue date, issue price, and, in some cases, the first payment of interest or interest
accruing prior to the issue date of such additional Notes). Such additional Notes may only be issued if they would be fungible with the applicable series of Notes for U.S. federal income tax purposes. Any additional Notes having such similar terms,
together with the applicable series of Notes issued on the date hereof, shall constitute a single series of Notes under the Indenture. No additional Notes may be issued if an Event of Default has occurred with respect to the applicable series of
Notes. 

  
 3 

 Section 2.02. Maturity. 

Unless an earlier redemption has occurred, the entire principal amount of the Notes shall mature and be due and payable, together with any accrued interest
thereon, on September 15, 2025. 
 Section 2.03. Form, Terms and Provisions. 

The Notes shall be issued as Global Notes, in fully registered form only and in minimum denominations of $200,000 and integral multiples of $1,000 in excess
thereof. The Notes and the Trustee’s Certificates of Authentication to be endorsed thereon are to be substantially in the form of Exhibit A, which form is hereby incorporated in and made a part of this Supplemental Indenture. The terms
and provisions contained in the Notes shall constitute, and are hereby expressly made, a part of this Supplemental Indenture, and the Company, the Parent Guarantor, the Trustee and the Designated Agents, by their execution and delivery of this
Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. 
 Section 2.04. Interest on the Notes. 

Interest on the Notes shall accrue at the rate of 4.250% per annum, from September 15, 2022 or the most recent interest payment date on which
interest was paid. Interest on the Notes shall be payable semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2023, to Holders in whose names the Notes are registered at the close of business on
the preceding March 1 and September 1 before the applicable interest payment date; provided that if any such interest payment date (other than September 15, 2025 or any earlier repayment date) is not a Business Day, the interest
payment date shall be postponed to the next succeeding Business Day, and no interest shall accrue as a result of such delayed payment on amounts payable from and after such interest payment date to the next succeeding Business Day. If
September 15, 2025 or any earlier repayment date of the Notes falls on a day that is not a Business Day, the payment of principal or interest otherwise payable on such date shall be postponed to the next succeeding Business Day, and no interest
on such payment shall accrue from and after September 15, 2025 or any earlier repayment date, as applicable. 
 Section 2.05. Purchase
Price. 
 The purchase price of the Notes is equal to 99.483% of the principal amount of the Notes, plus accrued interest, if any, from
September 15, 2022. 
 Section 2.06. Price to Public. 

The price to public of the Notes is equal to 99.683% of the principal amount of the Notes, plus accrued interest, if any, from September 15, 2022. 

  
 4 

 Section 2.07. Guarantees. 

The Notes shall have the benefit of the unconditional guarantee by the Parent Guarantor to pay the principal of, and premium if any, and interest, if any, and
any Additional Amounts on the Notes according to the terms of and as more fully described in the Indenture and the related Guarantee attached to the Notes. Reference is made to Article 14 of the Base Indenture and the Guarantee attached to the Notes
for the terms relating the Guarantee, including the release, termination and discharge thereof. 
 ARTICLE THREE 

COVENANTS 
 Section 3.01. Change
of Control. 
 In addition to the covenants set forth in Article Ten of the Base Indenture, the Notes shall be subject to the provisions described under
the heading “Change of Control” as set forth in the Global Notes representing the Notes attached hereto as Exhibit A. 
 Section 3.02.
Payment of Additional Amounts. 
 Section 10.10 of the Base Indenture shall be applicable to the Notes as set forth in the Global Notes
representing the Notes attached hereto as Exhibit A. 
 Section 3.03. Irish Stock Exchange Listing. 

The Company shall use its reasonable best efforts to cause the Notes to be listed and admitted to trading on the Global Exchange Market of The Irish Stock
Exchange plc trading as Euronext Dublin (“Euronext Dublin”) and shall from time to time take such other actions as shall be necessary or advisable to maintain the listing of the Notes thereon or another recognized securities
exchange. For so long as the Notes are listed on the Global Exchange Market of Euronext Dublin and the rules of the Global Exchange Market of Euronext Dublin so require, copies of the following items shall be available in physical form at
Mondelēz International, Inc., 905 West Fulton Market, Suite 200, Chicago, IL 60607: (i) the constitutional documents of the Company and the Parent Guarantor; (ii) the listing particulars; (iii) the consolidated audited financial
statements of the Parent Guarantor for the years ended December 31, 2021 and 2020; (iv) the guarantees; and (v) the Indenture. The Company shall promptly notify the Trustee in writing when the Notes are listed on any stock exchange and of
any delisting thereof. 
 ARTICLE FOUR 

REDEMPTION 
 Section 4.01.
Redemption for Tax Reasons. 
 The Company may, at its option, redeem the Notes in whole, but not in part, upon the occurrence of specified tax
events as set forth in the Global Notes representing the Notes attached hereto as Exhibit A. 

  
 5 

 Section 4.02. Optional Redemption. 

The Company may redeem the Notes in whole or in part, at its option, at a redemption price equal to 100% of their principal amount plus a
“make-whole” premium, as well as accrued and unpaid interest to, but not including, the date of redemption, as set forth in the Global Notes representing the Notes attached hereto as Exhibit A. The Trustee shall not be responsible for
calculating any “make-whole” premium. 
 ARTICLE FIVE 

DESIGNATED AGENTS 
 Section 5.01.
Appointment and Resignation of the Designated Agents. 
 (a) Paying Agent. The Company hereby appoints Deutsche Bank Trust
Company Americas as the Paying Agent in respect of the Notes. The Company may, with the prior approval of the Trustee, terminate the appointment of the Paying Agent at any time or appoint additional or other Paying Agents by giving to the Paying
Agent at least 90 days’ prior written notice to that effect provided that any of the Notes are outstanding. 
 (b) Registrar
and Transfer Agent. The Company hereby appoints Deutsche Bank Trust Company Americas as the Registrar and Transfer Agent for the purpose of registering Notes and transfers of registered Notes as provided under Section 3.6 of the Base
Indenture, and all references to “Security Registrar” in the Base Indenture with respect to the Notes shall be deemed to refer to the Registrar and Transfer Agent. The Registrar and Transfer Agent shall maintain a register at its office,
which is currently located at Deutsche Bank Trust Company Americas, 60 Wall Street, 24th floor, New York, New York 10005 (the register maintained in such office being referred to as the “Security Register”). 

(c) Authenticating Agent. The Company and the Trustee hereby appoint Deutsche Bank Trust Company Americas as the Authenticating Agent
pursuant to Section 6.12 of the Base Indenture; provided that (i) the sentence “Any such Authenticating Agent shall at all times be a corporation organized and doing business under the laws of the United States or of any State,
authorized under such laws of the United States or of any State, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of at least $50,000,000 and subject to supervision or examination by federal or
State authority” in the first paragraph of Section 6.12 of the Base Indenture shall not apply and (ii) Section 6.12 of the Base Indenture shall be amended to provide the Authenticating Agent the power to act on the Trustee’s
behalf under Section 3.4 (in addition to the powers under Sections 3.5, 3.6 and 11.7) of the Base Indenture with respect to authentication and delivery of the Notes, as fully to all intents and purposes as though such Authenticating Agent
had been expressly authorized by those Sections of the Base Indenture to authenticate and deliver Notes. 
 (d) Resignation of Designated
Agents; Appointment of Successors. All or any of the Designated Agents may resign their respective appointments under the Notes and this Indenture at any time by giving to the Company and, where appropriate, the Paying Agent and the Trustee at
least 90 days’ prior written notice to that effect provided that, so long as any of the Notes are outstanding, the notice shall not, in the case of the Paying Agent, expire less than 45 days before any due date for the payment of interest.
Following receipt of a notice of resignation from a 

  
 6 

 
Designated Agent, the Company shall promptly, and in any event not less than 30 days before the resignation takes effect, give notice to the Holders of the Notes in accordance with the Indenture.
If any Designated Agent shall resign or be removed, the Company shall promptly and in any event within 30 days appoint a successor approved by the Trustee. If the Company fails to appoint a successor within such period, the Paying Agent may select a
leading bank approved by the Company and the Trustee to act as Paying Agent hereunder and the Company shall appoint that bank as the successor Paying Agent. 

Section 5.02. Payment by the Company to the Paying Agent. 

(a) The Company shall, not later than 10:00 a.m. (New York City time) the Business Day immediately preceding each date on which any payment of
principal, premium, if any, or interest in respect of any of the Notes becomes due, transfer to an account specified by the Paying Agent such amounts as shall be sufficient for the purposes of the payment of principal, premium, if any, or interest
in same day funds. 
 (b) The Company shall ensure that, not later than the second London Business Day immediately preceding the date on
which any payment is to be made to the Paying Agent pursuant to paragraph (a) above, the Paying Agent shall receive a copy of an irrevocable payment instruction to the bank through which the payment is to be made. For the purposes of this
paragraph (b), “London Business Day” means a day on which banks are open for business in London. 
 (c) If any payment provided
for by paragraph (a) above is made late but otherwise under the terms of this Supplemental Indenture, the Paying Agent shall nevertheless act as a Paying Agent. However, (i) unless and until the full amount of any payment has been made to
the Paying Agent in accordance with paragraph (a) above or (ii) unless and until the Paying Agent is satisfied that such payment shall be made, it shall not be bound to make payments in respect of the Notes as aforesaid. 

Section 5.03. Obligations of the Paying Agent and the Company. 

(a) General Duties of the Paying Agent. Subject to the payments to the Paying Agent being duly made, the Paying Agent shall act as
paying agent of the Company in respect of the Notes and pay or cause to be paid on behalf of the Company, on and after each date on which any payment becomes due and payable, the amounts of principal, premium (if any) or interest then payable on
surrender or, in the case of a Global Note, endorsement, of Notes under the terms and conditions of the Notes and the Indenture. If any payment provided for by Section 5.02 hereof is made late but otherwise under the terms of the Notes and the
Indenture, the Paying Agent shall nevertheless act as paying agent following receipt by them of payment. While any Notes are represented by a Global Note, all payments due in respect of the Notes shall be made to, or to the order of, the holder of
the Global Note, subject to and in accordance with the provisions of the Global Note. 
 (b) Payment Default. If default is made by
the Company in respect of any payment, unless and until the full amount of the payment has been made under the terms of the Notes and the Indenture (except as to the time of making the same) or other arrangements satisfactory to the Paying Agent
have been made, the Paying Agent shall not be bound to act as paying agent. 

  
 7 

 (c) Payment Shortfall. Notwithstanding the foregoing, if the Paying Agent pays any
amounts to the Holders of Notes at a time when it has not received payment in full in respect of the Notes (the excess of the amounts so paid over the amounts so received being the “Shortfall”), the Company shall, in addition to
paying amounts due under Section 5.02 hereof, pay to the Paying Agent on demand interest (at a rate which represents the Paying Agent’s cost of funding the Shortfall) on the Shortfall (or the unreimbursed portion thereof) until the receipt
in full by the Paying Agent of the Shortfall. 
 (d) Notification of Non-Payment. The Paying
Agent shall notify the Trustee, by facsimile or electronically in PDF format, forthwith: (i) if it has not by the relevant date specified in Section 5.02 hereof received unconditionally the full amount required for the payment; and
(ii) if it receives unconditionally the full amount of any sum due in respect of the Notes after such date. The Paying Agent shall, at the expense of the Company, forthwith upon receipt of any amount as described under this subclause (ii),
cause notice of that receipt to be published. 
 (e) Duties in Connection with Redemption for Tax Reasons. If the Company decides to
redeem Notes pursuant to Section 4.01 hereof, the Paying Agent shall instruct the Security Registrar to make appropriate entries in their records in respect of all Notes redeemed by the Company to reflect such redemptions. 

(f) Publication of Notices. On behalf of and at the request and expense of the Company, the Paying Agent shall cause to be published
all notices required to be given by the Company under the terms and conditions contained in the Notes. 
 (g) Cancellation of Notes.
All Notes that are surrendered to the Paying Agent in connection with redemption shall be canceled by the Paying Agent. Where Notes are purchased by or on behalf of the Company or any of its subsidiaries, the Company shall immediately notify the
Paying Agent of the principal amount of those Notes it has purchased and may procure that the Notes are promptly canceled and delivered to the Paying Agent or its authorized agent. The Paying Agent or its authorized agent shall (unless otherwise
instructed by the Company) dispose of all canceled Notes and furnish the Company with evidence of disposal containing written particulars of the serial numbers of the Notes and the number so disposed. 

(h) Change of Office. If the Paying Agent shall change its specified office, it shall give to the Company and the Trustee not less than
45 days’ prior written notice to that effect giving the address of the new specified office. As soon as practicable thereafter and in any event at least 30 days before the change, the Paying Agent shall give to the Holders of Notes on behalf of
and at the expense of the Company notice of the change and the address of the new specified office. 
 (i) Additional Duties of the
Paying Agent. The Paying Agent undertakes to the Company that it will, in connection with the issue of the Notes, perform the duties which are stated to be performed by it in Schedule 1. 

  
 8 

 (j) Commissions and Expenses. The Company shall pay to the Paying Agent such
commissions in respect of the services of the Paying Agent as shall be agreed from time to time between the Company and the Paying Agent, and shall also pay an amount equal to any value added tax which may be payable in respect of the commissions
together with all reasonable expenses incurred by the Paying Agent in connection with its services. All payments by the Company under this paragraph and to the Trustee pursuant to Section 6.7 of the Base Indenture shall be made free and clear
of, and without withholding or deduction for, any taxes, duties, assessments or governmental charges of whatsoever nature imposed, levied, collected, withheld or assessed by any government having power to tax, unless such withholding or deduction is
required by law. In that event, the Company shall pay such additional amounts as will result in receipt by the Paying Agent of such amounts as would have been received by it if no such withholding had been required. 

(k) No Obligation to Act Under Certain Circumstances. Notwithstanding any other provision of the Notes or the Indenture, the Paying
Agent shall not be under any obligation to take any action under the Notes or the Indenture that it expects will result in any expense or liability accruing to it, the payment of which within a reasonable time is not, in its opinion, assured to it.

 Section 5.04. Indemnity and Limitation of Liability. 

(a) Indemnification of Paying Agent. The Company undertakes to indemnify the Paying Agent against all losses, liabilities, costs,
claims, actions, damages, expenses or demands which it may incur or which may be made against it as a result of or in connection with the appointment of or the exercise of its powers and duties under the Notes and the Indenture except as may result
from its own willful default, gross negligence or fraud. This indemnity shall survive any termination of this Agreement and the resignation or removal of the Paying Agent. 

(b) Limitation of Liability. The Designated Agents shall not be liable for any loss caused by events beyond their reasonable control
including any malfunction, interruption or error in the transmission of information caused by any machine or systems or interception of communication facilities, abnormal operating conditions or events of force majeure. Under no circumstances shall
the Designated Agents be liable to the Company in contract, tort (including negligence) or otherwise for any consequential, special, indirect, punitive or speculative loss or damage (including but not limited to loss of business, goodwill,
opportunity or profit) which arises out of or in connection with the Indenture even if advised of the possibility of such loss or damage. Each of the Designated Agents shall be protected and shall incur no liability for or in respect of action
taken, omitted or suffered in reliance upon any instruction, request or order from the Company or the Trustee or any document which it reasonably believes to be genuine and to have been delivered by the proper party or parties or upon written
instructions from the Company or the Trustee. 
 Section 5.05. General Provisions Applicable to the Designated Agents. 

(a) Several and Not Joint. The obligations and duties of the Designated Agents under the Notes and the Indenture shall be several and
not joint. 

  
 9 

 (b) No Implied Duties or Other Assumed Obligations. The Designated Agents shall only
be obliged to perform duties set out under the Notes and the Indenture, and shall have no implied duties. In acting under the terms of the Notes and the Indenture, the Designated Agents shall act solely as agents of the Company and shall not assume
any obligations towards or relationship of agency or trust for or with any of the owners or Holders of the Notes. 
 (c) Consultation
with Advisers. Each of the Designated Agents may consult with legal and other professional advisers at the reasonable expense of the Company and the opinion of the advisers shall be full and complete protection in respect of action taken,
omitted or suffered under the Indenture in good faith and in accordance with the opinion of the advisers. 
 (d) Other Engagements.
Any of the Designated Agents, their officers, directors or employees may become the owner of, or acquire any interest in, Notes with the same rights that it or he would have if the Designated Agent concerned were not appointed under this
Supplemental Indenture, and may engage or be interested in any financial or other transaction with the Company or the Trustee, and may act on, or as depositary, trustee or agent for, any committee or body of holders of Notes or other obligations of
the Company as freely as if the Designated Agent were not appointed under this Supplemental Indenture. 
 ARTICLE SIX 

MISCELLANEOUS 
 Section 6.01.
Application of Supplemental Indenture. 
 The Indenture, as supplemented by this Supplemental Indenture, is in all respects ratified and confirmed.
This Supplemental Indenture shall be deemed part of the Base Indenture in the manner and to the extent herein and therein provided. 
 Section 6.02.
Trust Indenture Act Controls. 
 If any provision hereof limits, qualifies or conflicts with the duties imposed by Sections 310 through 317 of the
Trust Indenture Act, the imposed duties shall control. 
 Section 6.03. Conflict with Base Indenture. 

To the extent not expressly amended or modified by this Supplemental Indenture, the Base Indenture shall remain in full force and effect, including, without
limitation, the rights, privileges and protections afforded to the Trustee thereunder. If any provision of this Supplemental Indenture relating to the Notes is inconsistent with any provision of the Base Indenture, the provision of this Supplemental
Indenture shall control. 

  
 10 

 Section 6.04. Governing Law; Waiver of Jury Trial. 

THIS SUPPLEMENTAL INDENTURE, THE NOTES AND THE GUARANTEES THEREOF SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 EACH OF THE COMPANY, THE PARENT GUARANTOR AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE OR THE TRANSACTION CONTEMPLATED HEREBY. 

Section 6.05. Successors. 
 All covenants and
agreements in this Supplemental Indenture, the Notes or the Base Indenture by each of the Company, the Parent Guarantor and the Trustee shall bind their respective successors and assigns, whether so expressed or not. 

Section 6.06. Counterparts. 
 This Supplemental
Indenture may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this
Supplemental Indenture by telecopier, facsimile or other electronic transmission (i.e., a “pdf” or “tif”) (including any electronic signature complying with the New York Electronic Signatures and Records Act (N.Y. State Tech.
§§ 301-309), as amended from time to time, or other applicable law) shall be effective as delivery of a manually executed counterpart thereof. The use of electronic signatures and electronic records
(including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a
paper-based recordkeeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable
law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code. 
 Section 6.07.
Trustee Disclaimer. 
 With respect to the recitals contained herein and in the Securities, except the Trustee’s certificates of authentication
thereof, neither the Trustee, nor any Authenticating Agent assumes any responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Supplemental Indenture or of the Notes. Neither the Trustee
for the Notes nor any Authenticating Agent shall be accountable for the use or application by the Company of the Notes or the proceeds thereof. 

Section 6.08. Modification to Base Indenture. 
 With
respect to the Notes and any other series of Securities issued under the Base Indenture on or after the date hereof: 

  
 11 

 (a) Section 3.4 of the Base Indenture is hereby amended by inserting the word “, division”
after the word “conversion” in the last paragraph; 
 (b) Section 6.11 of the Base Indenture is hereby amended by inserting the word “,
division” after each instance of the word “conversion”; 
 (c) Section 6.12 of the Base Indenture is hereby amended by inserting the
word “, division” after the word “conversion” in the second paragraph; 
 (d) Section 8.1 of the Base Indenture is hereby amended
by: 
 (i) inserting the word “, division” after the word “merger” in paragraph (5); and 

(ii) adding the following language as a new paragraph: 

“Any reference herein to a merger, consolidation, amalgamation, assignment, sale, disposition or transfer, or similar term, shall be
deemed to apply to a division of or by a limited liability company, limited partnership or trust, or an allocation of assets to a series of a limited liability company, limited partnership or trust (or the unwinding of such a division or
allocation), as if it were a merger, consolidation, amalgamation, assignment, sale, disposition or transfer, or similar term, as applicable, to, of or with a separate Person. Any division of a limited liability company, limited partnership or trust
shall constitute a separate Person hereunder (and each division of any limited liability company, limited partnership or trust that is a Subsidiary, joint venture or any other like term shall also constitute such a Person or entity).”; 

(e) Section 10.7 of the Base Indenture is hereby amended by replacing the parenthetical in the third line of paragraph (a)(3) with the phrase
“(including through a merger, share exchange, division or consolidation)”; and 
 (f) Section 10.10 of the Base Indenture is hereby amended
by deleting the current language in paragraph (g) and replacing it with “[reserved]”. 
 Section 6.09. U.S.A. Patriot Act.

 The parties hereto acknowledge that in order to help the United States government fight the funding of terrorism and money laundering activities,
pursuant to Federal regulations that became effective on October 1, 2003 (Section 326 of the USA PATRIOT Act) all financial institutions are required to obtain, verify, record and update information that identifies each person establishing a
relationship or opening an account. The parties to this Supplemental Indenture agree that they shall provide to the Trustee such information as it may request, from time to time, in order for the Trustee to satisfy the requirements of the USA
PATRIOT Act, including but not limited to the name, address, tax identification number and other information that will allow it to identify the individual or entity who is establishing the relationship or opening the account and may also ask for
formation documents such as articles of incorporation or other identifying documents to be provided. 

  
 12 

 Section 6.10. Force Majeure. 

The Trustee shall not incur any liability for not performing any act or fulfilling any duty, obligation or responsibility hereunder by reason of any
occurrence beyond the control of the Trustee (including but not limited to any act or provision of any present or future law or regulation or governmental authority, any act of God or war, civil unrest, local or national disturbance or disaster, any
act of terrorism, or the unavailability of the Federal Reserve Bank wire or facsimile or other wire or communication facility). 
 Section 6.11.
Notices. 
 (a) Any notice required to be given under this Supplemental Indenture to any of the parties shall be in English in writing and shall be
delivered in person, sent by pre-paid post (first class if domestic, first class airmail if international) or by facsimile or email in PDF format addressed to: 

 

	The Company:	 Mondelēz International, Inc. 

	 	 905 West Fulton Market, Suite 200 

	 	 Chicago, Illinois 60607 

	 	 United States 

	 	 Email: william.whisler@mdlz.com 

	 	 Attention: William Whisler, Assistant Treasurer 

 

	The Trustee:	 Deutsche Bank Trust Company Americas 

	 	 60 Wall Street, 24th floor 

	 	 New York, New York 10005 

	 	 United States 

	 	 Fax: +1 (732) 578 4635 

	 	 Attention: Corporates Team / Mondelez International 

	 	 Holdings Netherlands B.V. 

 

	The Paying Agent:	 Deutsche Bank Trust Company Americas 

	 	 60 Wall Street, 24th floor 

	 	 New York, New York 10005 

	 	 United States 

	 	 Fax: +1 (732) 578 4635 

	 	 Attention: Corporates Team / Mondelez International Holdings Netherlands B.V. 

 

	The Registrar and Transfer Agent:	 Deutsche Bank Trust Company Americas 

	 	 60 Wall Street, 24th floor 

	 	 New York, New York 10005 

	 	 United States 

	 	 Fax: +1 (732) 578 4635 

	 	 Attention: Corporates Team / Mondelez International Holdings Netherlands B.V. 

(b) Any notice required to be given under the Notes to Holders shall be in accordance with the procedures of The Depository Trust Company. 

  
 13 

 IN WITNESS WHEREOF, the parties to this Supplemental Indenture have caused it to be duly
executed as of the day and year first above written. 
  

			
	MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V.
		
	By:	 	 Birgit Beijersbergen van Henegouwen-Bekkers

	Name:	 	Birgit Beijersbergen van Henegouwen-
		 	Bekkers
	Title:	 	Director

  
 [Signature Page
to Supplemental Indenture] 

 
			
	MONDELĒZ INTERNATIONAL, INC.
		
	By:	 	 /s/ Vitus Alig

	Name:	 	Vitus Alig
	Title:	 	Senior Vice President, Corporate FP&A
		 	and Treasurer

  
 [Signature Page
to Supplemental Indenture] 

 
			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	 /s/ Kathryn Fischer

		 	Name: Kathryn Fischer
		 	Title: Vice President
		
	By:	 	 /s/ Irina Golovashchuk

		 	Name: Irina Golovashchuk
		 	Title: Vice President

  
 [Signature Page
to Supplemental Indenture] 

 
			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent
		
	By:	 	 /s/ Kathryn Fischer

		 	Name: Kathryn Fischer
		 	Title: Vice President
		
	By:	 	 /s/ Irina Golovashchuk

		 	Name: Irina Golovashchuk
		 	Title: Vice President

  
 [Signature Page
to Supplemental Indenture] 

 
			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Registrar and Transfer Agent
		
	By:	 	 /s/ Kathryn Fischer

		 	Name: Kathryn Fischer
		 	Title: Vice President
		
	By:	 	 /s/ Irina Golovashchuk

		 	Name: Irina Golovashchuk
		 	Title: Vice President

  
 [Signature Page
to Supplemental Indenture] 

 Exhibit A 

[Face of Note] 
 [Insert the
Global Security Legend, if applicable pursuant to the provisions of the Indenture] 
 [Insert the Private Placement Legend, if applicable
pursuant to the provisions of the Indenture] 
 [Insert the Regulation S Temporary Global Security Legend, if applicable pursuant to the
provisions of the Indenture] 

  
 A-1 

					
		 	CUSIP:	  	[            ]1
		 	ISIN:	  	[            ]2
		 	Common Code:	  	[            ]3

 [RULE 144A][REGULATION S] GLOBAL NOTE 

representing up to 

$[     ] 

4.250% Notes due 2025 
 MONDELEZ
INTERNATIONAL HOLDINGS NETHERLANDS B.V. 
  

			
	No. [     ]	  	$[            ]

 MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V., a private company with limited liability (besloten
vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (hereinafter called the “Issuer,” which term includes any successor Person under the Indenture hereinafter referred to) and an indirect,
wholly owned subsidiary of Mondelēz International, Inc., a Virginia Corporation (hereinafter called the “Parent” or the “Parent Guarantor,” which term includes any successor Person under the Indenture
hereinafter referred to), for value received, hereby promises to pay to Cede & Co. or registered assigns, the principal sum [set forth on the Schedule of Exchanges of Interests in the Global Note attached hereto][of
$[     ] ([     ] DOLLARS)] on September 15, 2025. The issue date of this note is September [     ], 2022. 

Interest Payment Dates: March 15 and September 15 of each year, beginning on March 15, 2023 

Record Dates: March 1 and September 1 
 If any
Interest Payment Date is not a business day, the Interest Payment Date shall be postponed to the next succeeding business day, and no interest shall accrue as a result of such delayed payment on amounts payable from and after such Interest Payment
Date to the next succeeding business day. 
  

	1 	 CUSIP: 144A: 60920LAS3; Regulation S: N6000L AR6 

	2 	 ISIN: 144A: US60920LAS34; Regulation S: USN6000LAR61 

	3 	 Common Code: 144A: 253299860; Regulation S: 253529652

  
 A-2 

 The interest so payable, and punctually paid or duly provided for, on any Interest Payment
Date will, as provided in the Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on the preceding March 1 and September 1 (each, a “Record Date”)
before the applicable Interest Payment Date. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holders on such date and may be paid to the Person in whose name this Note (or one or more
Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee for the Notes, notice whereof shall be given to Holders of Notes not less than 10 days
prior to such Special Record Date, or may be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange,
all as more fully provided in said Indenture. 
 Payment of the principal of, premium, if any, and interest on this Note shall be made at
the office or agency of the Issuer maintained for that purpose in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private
debts; provided, however, that at the option of the Issuer payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear on the Securities Register or by wire transfer to an
account maintained by the payee at a bank located in the United States. All payments of principal, premium, if any, and interest in respect of this Note shall be made by the Issuer in immediately available funds. 

As used herein, “business day” means a day, other than a Saturday or Sunday, which is not a day on which banking institutions in New
York are authorized or required by law, regulation or executive order to close. 
 Interest on the Notes shall be computed and paid on the
basis of a 360-day year consisting of twelve 30-day months. The interest rate on the Notes will in no event be higher than the maximum rate permitted by New York law, as
the same may be modified by United States law of general application. 
 If the maturity date or a date fixed for redemption is not a
business day, then payment of interest or principal need not be made on such date, but may be made on the next succeeding business day, in each case with the same force and effect as if made on the scheduled maturity date or such date fixed for
redemption, and no interest shall accrue as a result of such delayed payment on amounts payable from and after the scheduled maturity date or such Redemption Date, as the case may be, to the next succeeding business day. 

Additional provisions of this Note are contained on the reverse hereof, and such provisions shall have the same effect as though fully set
forth in this place. 
 Unless the Certificate of Authentication hereon has been executed by or on behalf of the Trustee for the Notes by
manual signature, this Note shall not be entitled to any benefit under the Indenture, or be valid or obligatory for any purpose. 

(Signature Page Follows) 

  
 A-3 

 IN WITNESS WHEREOF, MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V. has caused this
instrument to be duly executed. 
 Dated: September [    ], 2022. 

 

			
	MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V.
		
	By:	 	
                     
        

		 	Name:
		 	Title:

  
 A-4 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein described in the within-mentioned Indenture. 

 

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	
                 

		 	Authorized Signatory

 Dated: September [    ], 2022 

  
 A-5 

 (Reverse of Note) 

MONDELEZ INTERNATIONAL HOLDINGS NETHERLANDS B.V. 

This Note is one of a duly authorized issue of debentures, Notes or other evidences of indebtedness (hereinafter called the
“Securities”) of the Issuer of the series hereinafter specified, all such Securities issued and to be issued under an Indenture dated as of October 28, 2016 (herein called the “Base Indenture”), as supplemented
by the sixth supplemental indenture, dated as of September 15, 2022 (the “Sixth Supplemental Indenture” and, the Base Indenture, as supplemented and modified by the Sixth Supplemental Indenture, the “Indenture”)
between the Issuer, the Parent, Deutsche Bank Trust Company Americas, as Trustee (the “Trustee”), Deutsche Bank Trust Company Americas, as paying agent (the “Paying Agent”) and Deutsche Bank Trust Company Americas,
as registrar and transfer agent (the “Registrar and Transfer Agent”), to which Indenture and all other indentures supplemental thereto reference is hereby made for a statement of the rights and limitations of rights
thereunder of the Holders of the Securities and of the rights, obligations, duties and immunities of the Trustee for each series of Securities and of the Issuer and Parent, and the terms upon which the Securities are and are to be authenticated and
delivered. As provided in the Indenture, the Securities may be issued in one or more series, which different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest, if any, at different rates,
may be subject to different redemption provisions, if any, may be subject to different sinking, purchase or analogous funds, if any, may be subject to different covenants and Events of Default and may otherwise vary as in the Indenture provided or
permitted. This Note is one of a series of the Securities designated therein as 4.250% Notes due 2025 (the “Notes”). 
 The
Notes have the benefit of the unconditional guarantee by the Parent to pay the principal of, and premium if any, and interest, if any, on the Notes according to the terms of and as more fully described in the Indenture and the related Guarantee
included herein. Reference is made to Article 14 and the Guarantee included herein for the terms relating the Guarantee, including the release, termination and discharge thereof. 

The Issuer may, without the consent of the Holders of the Notes, issue additional Notes having the same ranking and the same interest rate,
maturity and other terms as the Notes, except for the issue price, issue date and, in some cases, the first payment of interest or interest accruing prior to the issue date of such additional Notes. Any additional Notes having such similar terms,
together with the Notes, shall constitute a single series of Notes under the Indenture. No additional Notes may be issued if an Event of Default has occurred with respect to the Notes. 

Change of Control 
 If a Change of Control
Triggering Event (as defined below) occurs, unless the Issuer has exercised its right to redeem the Notes upon the occurrence of specified events as described below under “—Redemption for Tax Reasons,” Holders may require the Issuer
to repurchase all or any part (equal to $200,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant to an offer (the “Change of Control Offer”) of payment in cash equal to 101% of the

  
 A-6 

 
aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to the date of purchase (the “Change of Control Payment”).
Within 30 days following any Change of Control Triggering Event, the Issuer shall mail a notice to Holders (with a copy to the Trustee) describing the transaction or transactions that constitute the Change of Control Triggering Event and offering to
repurchase the Notes on the date specified in the notice, which date shall be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures
described in such notice. The Issuer must comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and any other securities laws
and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control provisions of the Notes, the Issuer shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under the Change of Control provisions of
the Notes by virtue of such conflicts. 
 On the Change of Control Payment Date, the Issuer will, to the extent lawful: 

 

	 	•	 	 accept for payment all Notes or portions of Notes properly tendered pursuant to the Change of Control Offer;

  

	 	•	 	 deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and 

  

	 	•	 	 deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers’
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. 

 The Paying Agent
shall promptly mail to each Holder of Notes properly tendered the purchase price for the Notes, and the Trustee shall promptly authenticate and mail (or cause to be transferred by book-entry) to each Holder a new Note equal in principal amount to
any unpurchased portion of any Notes surrendered; provided that each new Note shall be in a principal amount of $200,000 or an integral multiple of $1,000 in excess thereof. 

The Issuer shall not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes
such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Issuer and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

For purposes of the foregoing discussion of a repurchase at the option of Holders, the following definitions are applicable: 

“Below Investment Grade Rating Event” means the Notes are rated below an Investment Grade Rating by each of
the Rating Agencies (as defined below) on any date from the date of the first public notice of an arrangement that could result in a Change of Control until the end of the 60-day period following public notice
of the occurrence of the Change of Control (which 60-day period shall be extended so long as the rating of the 

  
 A-7 

 
Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies); provided that a Below Investment Grade Rating Event otherwise arising by virtue of a
particular reduction in rating shall not be deemed to have occurred in respect to a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event
hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing that the reduction was the result, in whole or in part, of any event
or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event). 

“Change of Control” means the occurrence of any of the following: (i) the direct or indirect sale,
transfer, conveyance or other disposition (other than by way of merger, consolidation or division), in one or a series of related transactions, of all or substantially all of the properties or assets of Parent and its subsidiaries taken as a whole
to any Person or group of related persons for purposes of Section 13(d) of the Exchange Act (a “Group”) other than Parent or one of its subsidiaries; (ii) the approval by the holders of the Issuer’s or Parent’s
common stock of any plan or proposal for the liquidation or dissolution of the Issuer or Parent (whether or not otherwise in compliance with the provisions of the Indenture); (iii) the consummation of any transaction (including, without limitation,
any merger, consolidation or division) the result of which is that any Person or Group becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of Parent’s or Issuer’s voting stock; or
(iv) the first day on which a majority of the members of Parent’s Board of Directors are not Continuing Directors. 

“Change of Control Triggering Event” means the occurrence of both a Change of Control and a Below Investment
Grade Rating Event. 
 “Continuing Directors” means, as of any date of determination, any member of the
Board of Directors of Parent who (1) was a member of such Board of Directors on the date of the issuance of the Notes; or (2) was nominated for election or elected to such Board of Directors with the approval of a majority of the
Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of Parent’s proxy statement in which such member was named as a nominee for election as a
director, without objection to such nomination). 
 “Investment Grade Rating” means a rating equal to or
higher than Baa3 (or the equivalent) by Moody’s and BBB- (or the equivalent) by S&P, respectively. 

“Moody’s” means Moody’s Investors Service, Inc., or any successor to the rating agency business
thereof. 
 “Person” has the meaning set forth in the Indenture and includes a “person” as used in
Section 13(d)(3) of the Exchange Act. 

  
 A-8 

 “Rating Agencies” means (1) each of Moody’s and
S&P; and (2) if any of Moody’s or S&P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Issuer’s control, a “nationally recognized statistical rating
organization” within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act, selected by the Issuer (as certified by a resolution of its Board of Directors) as a replacement agency for
Moody’s or S&P, or all of them, as the case may be. 
 “S&P” means Standard &
Poor’s Financial Services LLC, a division of S&P Global, Inc., or any successor to the rating agency business thereof. 
 Optional Redemption

 The Notes shall be redeemable, as a whole or in part, at the Issuer’s option, at any time and from time to time on at least 15
days’, but not more than 60 days’, prior notice (with written notice to the Trustee no less than 15 days (or such shorter period as agreed by the Trustee) prior to the sending of such redemption notice in the event the Trustee is engaged
by the Issuer to send such notice in its name and at its expense). The redemption price shall be equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2) the sum of the present values of each remaining
scheduled payment of principal and interest thereon (exclusive of interest accrued to the date of redemption) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of
twelve 30-day months) at the Treasury Rate (as defined below) plus 15 basis points, plus accrued and unpaid interest on the principal amount of the Notes to, but not including, the date of redemption. 

“Redemption Date” means any date fixed for redemption of Notes. 

“Treasury Rate” means, with respect to any Redemption Date, the yield determined by the Company in accordance with the
following two paragraphs: 
 The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected Interest Rates (Daily) - H.15” (or any successor designation or publication)
(“H.15”) under the caption “U.S. government securities–Treasury constant maturities–Nominal” (or any successor caption or heading). In determining the Treasury Rate, we shall select, as applicable: (1) the yield
for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the maturity date (the “Remaining Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the
Remaining Life, the two yields—one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life—and
shall interpolate to the maturity date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or
longer than the Remaining Life, the yield for the single Treasury constant 

  
 A-9 

 
maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to
the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date. 
 If on the third
business day preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at
11:00 a.m., New York City time, on the second business day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to the maturity date. If there is no United States Treasury security
maturing on the maturity date but there are two or more United States Treasury securities with a maturity date equally distant from the maturity date, one with a maturity date preceding the maturity date and one with a maturity date following the
maturity date, the Company shall select the United States Treasury security with a maturity date preceding the maturity date. If there are two or more United States Treasury securities maturing on the maturity date or two or more United States
Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of
the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States
Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. 

The Company’s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. 
 On or before the Redemption Date, the Issuer shall deposit with the Trustee money sufficient to pay the redemption price
of and (unless the Redemption Date shall be an interest payment date) accrued interest to the Redemption Date on the Notes to be redeemed on such date. The Trustee shall not be responsible for calculating any “make-whole” premium. If less
than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee by lot, pro rata or by such method as the Trustee shall deem fair and appropriate in each case in accordance with the applicable procedures of DTC.
On and after the Redemption Date, interest shall cease to accrue on the Notes or any portion of the Notes called for redemption (unless the Issuer defaults in the payment of the redemption price and accrued interest). After the Redemption Date,
holders of Notes that were redeemed shall have no rights with respect to the Notes except the right to receive the redemption price and any unpaid interest to the Redemption Date. 

Payment of Additional Amounts 
 All
payments by the Issuer, the Parent Guarantor or the Paying Agent (each referred to in this section as a “Payor”) with respect to any Note or Guarantee shall be made free and clear of and without withholding or deduction for or on
account of any present or future tax, assessment or other governmental charge and any applicable interest and penalties (collectively “Taxes”), unless the withholding or deduction of such amounts is required by law or the official
interpretation thereof. 

  
 A-10 

 The Issuer or Parent, as applicable, will, subject to the exceptions and limitations set
forth below, pay such additional amounts as may be necessary to ensure that every net payment on such Note or guarantee, after deduction or withholding by the applicable withholding agent for or on account of any present or future Tax imposed upon
or as a result of such payment by any jurisdiction in which the Issuer or Parent is incorporated or organized, resident or engaged in business for tax purposes, or from or through which payment is made by or on behalf of the Issuer or Parent, or, in
each case, any political subdivision thereof or therein (each a “Relevant Taxing Jurisdiction”), including any such deduction or withholding attributable to the payment of such additional amounts, shall not be less than the amount
provided in such Note to be then due and payable absent such deduction or withholding (such additional amounts, the “Additional Amounts”). However, the Issuer and Parent shall not pay Additional Amounts (including, for the avoidance
of doubt, any such amount in respect of the payment of Additional Amounts) for or on account of: 
 (a) any Tax that is
imposed or withheld solely by reason of the existence of any present or former connection (other than a connection arising solely from the ownership of those Notes, the receipt of payments in respect of those Notes or the guarantee, or the
enforcement of any rights with respect to those Notes or the guarantee) between the holder or the beneficial owner (or between a fiduciary, settlor, beneficiary, member, partner or shareholder of such holder or beneficial owner if such holder is an
estate, trust, partnership, limited liability company, other fiscally transparent entity or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder or beneficial owner) of the Notes and the applicable
Relevant Taxing Jurisdiction, including without limitation citizenship, nationality, residence, domicile or the existence of a business, permanent establishment, a dependent agent or a place of management present or deemed present in the applicable
Relevant Taxing Jurisdiction; 
 (b) any Tax which would not have been imposed but for the presentation of such Note for
payment on a date more than 30 days after the date on which such payment became due and payable or the date on which such payment is duly provided for, whichever occurs later; 

(c) any Tax that is payable by any method other than withholding or deduction in respect of any payments under or, in respect
of, such Note or the guarantee; 
 (d) any gift, estate, inheritance, sales, transfer, personal property or any similar Tax;

 (e) any Tax if the holder could have avoided such Tax by presenting the relevant Notes for payment to another paying
agent; 

  
 A-11 

 (f) any Tax imposed or withheld as a result of the failure of the Holder or
beneficial owner of a Note to comply with a request to comply with applicable certification, information, documentation or other reporting requirements concerning the nationality, residence, identity or connection with any jurisdiction of the holder
or beneficial owner of a Note or to satisfy any information or reporting requirement, if such compliance is required by statute or regulation of the Relevant Taxing Jurisdiction or by an applicable income tax treaty to which the Relevant Taxing
Jurisdiction is a party as a precondition to relief or exemption from such Tax by the Relevant Taxing Jurisdiction; provided, in each case, that the holder or beneficial owner is legally eligible to satisfy such requirement; 

(g) any Tax imposed on or with respect to any payment to a holder if such holder is a fiduciary, limited liability company,
partnership, other fiscally transparent entity or other Person other than the sole beneficial owner of the applicable Note to the extent that such Tax would not have been imposed on such payment had the beneficiary, settlor, partner, member or other
beneficial owner directly held the Note; 
 (h) any Tax imposed under Sections 1471 through 1474 of the Internal Revenue Code
of 1986, as amended (the “Code”) as of the issue date (or any amended or successor provision that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official
interpretations thereof, any agreement entered into pursuant to current Section 1471(b) of the Code (or any amended or successor version described above) or any fiscal or regulatory legislation, rules or practices adopted pursuant to any
intergovernmental agreement (or related laws or official administrative practices) implementing the foregoing; 
 (i) any
U.S. federal Tax imposed on a beneficial owner that actually or constructively owns 10% or more of the total combined voting power of all of the Issuer or Parent’s stock that is entitled to vote within the meaning of Section 871(h)(3) of
the Code; 
 (j) any U.S. federal backup withholding Tax imposed pursuant to Section 3406 of the Code; 

(k) any Tax imposed pursuant to the Dutch Withholding Tax Act 2021 (Wet bronbelasting 2021) on any payments made or
deemed to be made by the Issuer to a related party (within the meaning of the Dutch Withholding Tax Act 2021 (Wet bronbelasting 2021)); 

or 

(l) any combination of items (a) through (k) above 

The Issuer shall pay any stamp, issue, registration, court or documentary Taxes or any other excise or similar Taxes that are levied by any
Relevant Taxing Jurisdiction and required by such Relevant Taxing Jurisdiction to be paid on the execution, delivery, issuance, or registration of any of the Notes, the Indenture, any guarantee or any other document referred to therein, the receipt
of any payments with respect thereto (but excluding, solely in the case of such payments, any Taxes described in clause (a), (b), or (d) through (j) or any combination of the foregoing), or 

  
 A-12 

 
enforcement of, any of the Notes or any guarantee. The Issuer shall not, however, be obligated to pay any stamp, issue, registration, court or documentary Taxes, or any other excise or similar
Tax, that is levied by any Relevant Taxing Jurisdiction in connection with any transfer of a Note or a beneficial interest in a Note to a Person other than the Issuer or Parent after the date of issuance of the Notes. 

If a Payor is the applicable withholding agent, each of the Issuer and Parent shall (i) make all withholdings and deductions for Taxes
with respect to payments under the Notes or the guarantee that it is required by law or the official interpretation thereof to make, and shall remit the full amount deducted or withheld to the relevant tax authority in accordance with applicable law
(ii) use its reasonable efforts to obtain tax receipts from each tax authority evidencing the payment of any Taxes so deducted or withheld and (iii) furnish to the Trustee, within a reasonable time after the date of the payment of any such
Taxes, certified copies of such Tax receipts evidencing any such payment, or if, notwithstanding its efforts to obtain receipts, receipts are not available, other evidence of such payments. 

The above obligations shall survive any termination, defeasance or discharge of the Indenture and any transfer by a holder or beneficial owner
of its Notes, and shall apply, mutatis mutandis, to any jurisdiction in which any successor Person to the Issuer or Parent is incorporated or organized, resident or engaged in business for Tax purposes or any jurisdiction from or through
which any payment on the Notes (or any Guarantee) is made by or on behalf of such Person and, in each case, any political subdivision thereof or therein. 

Whenever in the Indenture or in this Note there is mentioned, in any context, the payment of amounts based upon the principal amount of the
Notes or of principal, interest or of any other amount payable under, or with respect to, any of the Notes or any guarantee, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context,
Additional Amounts are, were or would be payable in respect thereof. 
 At least 10 days prior to the first Interest Payment Date, and at
least 10 days prior to each date of payment of principal, premium, if any, and interest, if any, if there has been any change with respect to the matters set forth in the below mentioned Officers’ Certificate, the Issuer shall furnish the
Trustee and the Issuer’s principal Paying Agent or Paying Agents, if other than such Trustee, with an Officers’ Certificate instructing such Trustee and such Paying Agent or Paying Agents whether such payment of principal of, and premium,
if any, and interest, if any, on the Notes shall be made to Holders without withholding for or on account of any tax, assessment or other governmental charge referred to above or described herein. If any such withholding shall be required, then such
Officers’ Certificate shall specify by country the amount, if any, required to be withheld on such payments to such Holders and the Issuer or the Parent, as the case may be, shall pay to the Trustee or such Paying Agent such Additional Amounts
as may be required pursuant to the terms hereof. The Issuer covenants to indemnify the Trustee for the Notes and any Paying Agent for, and to hold them harmless against, any loss, liability or expense reasonably incurred without gross negligence or
willful misconduct on their part arising out of or in connection with actions taken or omitted by any of them in reliance on any Officers’ Certificate furnished pursuant to Section 10.10 of the Base Indenture. For the avoidance of doubt,
the Trustee shall not at any time be under any duty or responsibility to any Holder to determine the Additional Amounts, or with respect to the nature, extent, or calculation of the amount of any Additional Amounts owed, or with respect to the
method employed in such calculation of any Additional Amounts. 

  
 A-13 

 Redemption for Tax Reasons 

The Issuer may redeem the Notes prior to maturity in whole, but not in part, on not more than 60 days’ notice and not less than 30
days’ notice (with written notice to the Trustee no less than 15 days (or such shorter period as agreed by the Trustee) prior to the sending of such redemption notice in the event the Trustee is engaged by the Issuer to send such notice or
cause such notice to be sent in its name and at its expense) at a redemption price equal to the principal amount of such Notes plus any accrued interest and Additional Amounts to, but not including, the date fixed for redemption if as a result of a
change in or amendment to the tax laws, regulations or rulings of the Relevant Taxing Jurisdiction or any change in official position regarding the application or interpretation of such tax laws, regulations or rulings (including by virtue of a
holding by a court of competent jurisdiction in the Relevant Taxing Jurisdiction), which change or amendment becomes effective after the issuance of such Notes (or, if the Relevant Taxing Jurisdiction becomes a Relevant Taxing Jurisdiction after the
issuance of such Notes, after the Relevant Taxing Jurisdiction becomes a Relevant Taxing Jurisdiction), the Issuer becomes or will become obligated to pay Additional Amounts with respect to the Notes as described above under “—Payment of
Additional Amounts,” and the Issuer, in its business judgment, determines that such obligations cannot be avoided by the use of reasonable measures available to the Issuer; provided that (1) no notice of redemption may be given earlier
than 90 days prior to the earliest date on which we would be obligated to pay the Additional Amounts giving rise to the redemption if a payment on the applicable Notes were then due and (2) at the time such notice of redemption is given the
obligation to pay such Additional Amounts remains in effect. 
 If the Issuer exercises its option to redeem the Notes, the Issuer shall
deliver to the Trustee a certificate signed by an authorized officer stating that the Issuer is entitled to redeem the Notes, along with (i) an opinion of independent tax counsel of recognized expertise in the laws of the Relevant Taxing
Jurisdiction selected by the Issuer to the effect that a change in law as described above exists and (ii) an Officer’s Certificate to the effect that it cannot avoid its obligation to pay Additional Amounts by the Issuer taking reasonable
measures available to it. The Trustee and the Paying Agent shall accept and shall be entitled to conclusively rely upon such Officer’s Certificate and opinion of counsel as sufficient evidence of the satisfaction of the conditions precedent
described above for the Issuer to exercise its right to redeem the Notes, which determination shall be conclusive and binding on the holders of the Notes. 

Defeasance 
 The Indenture contains
provisions for defeasance at any time of the entire principal of all the Securities upon compliance by the Issuer with certain conditions set forth therein. 

Certain of the Issuer’s obligations under the Indenture with respect to Notes, may be terminated if the Issuer irrevocably deposits with
the Trustee money or Government Obligations sufficient to pay and discharge the entire indebtedness on the Indenture. 

  
 A-14 

 Events of Default 

Section 5.1(a) of the Indenture shall be applicable to the Notes. If an Event of Default (other than an Event of Default described in
Section 5.1(a)(4) or 5.1(a)(5) of the Indenture) with respect to the Notes shall occur and be continuing, then either the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes of this series then Outstanding may
declare the entire principal amount of the Notes together with accrued interest on the Notes of this series due and payable in the manner and with effect provided in the Indenture. If an Event of Default specified in Section 5.1(a)(4) or
Section 5.1(a)(5) of the Indenture occurs with respect to the Issuer, all of the unpaid principal amount and accrued interest then outstanding shall ipso facto become and be immediately due and payable in the manner and with the effect provided
in the Indenture without any declaration or other act by the Trustee or any Holder. 
 Amendments 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of
the Issuer and the rights of the Holders of the Securities under the Indenture at any time by the Issuer with the consent of the Holders of more than 50% in aggregate principal amount of the Securities at the time Outstanding of each series issued
under the Indenture to be affected thereby. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the Securities of that series at the time Outstanding, on behalf of the Holders of
all the Securities of such series, to waive compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences with respect to such series. Any such consent or waiver by the Holder
of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the transfer hereof or in exchange or in lieu hereof whether or not notation of such consent or waiver is made upon
this Note. 
 Payment 
 No reference
herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Issuer, which is absolute and unconditional, to pay the principal of and interest on this Note at the times, place and rate, and in
the coin or currency, herein and in the Indenture prescribed. 
 Transfer, Registration and Exchange 

The Notes are in registered form without coupons in denominations of $200,000 and integral multiples of $1,000 in excess thereof. The transfer
of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Security Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and the Issuer may
require a Holder to pay any taxes and fees required by law or permitted by the Indenture. 

  
 A-15 

 No service charge shall be made for any such registration of transfer or exchange, but the
Issuer may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 The Issuer,
the Trustee for the Notes and any agent of the Issuer or such Trustee may treat the Person in whose name this Note is registered as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not
this Note be overdue, and neither the Issuer, such Trustee nor any such agent shall be affected by notice to the contrary. 
 The Notes are
not subject to a sinking fund. 
 This Note shall for all purposes be governed by, and construed in accordance with, the laws of the
State of New York. 
 Certain terms used in this Note which are defined in the Indenture have the meanings set forth therein. 

  
 A-16 

 ASSIGNMENT FORM 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto: 

PLEASE INSERT SOCIAL SECURITY NUMBER OR OTHER IDENTIFYING NUMBER OF ASSIGNEE 
  

 
 (Name and address of Assignee,
including zip code, must be printed or typewritten) 
  
  

 
  

the within Note, and all rights thereunder, hereby irrevocably, constituting and appointing 

 
  
  

 
 to transfer the said Note on the books of Mondelez
International Holdings Netherlands B.V. with full power of substitution in the premises. 
  

					
	Dated:                     	 		 	              

		 		 	NOTICE: The signature to this assignment must correspond with the name as it appears upon the face of the within Note in every particular, without alteration or enlargement or any change whatever.

  
 A-17 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part
of another Global Security or Definitive Security for an interest in this Global Note, have been made: 
  

									
	 Date of

Exchange
	 	 Amount of

decrease
 in Principal

Amount of this Global Note
	 	 Amount of increase

in Principal
 Amount of this

Global Note
	 	 Principal Amount

of
 this Global Note

following such
 decrease or

increase
	 	 Signature of

authorized officer
 of Trustee or

Note custodian

  
 A-18 

 GUARANTEE 

For value received, the Parent Guarantor hereby fully and unconditionally guarantees the due and punctual payment of all of the obligations of
the Issuer under the Indenture and the Securities, whether for the payment of principal, of premium, if any, or interest or any Additional Amounts on the Securities or otherwise, when and as the same shall become due and payable, whether at
maturity, upon redemption or otherwise. This Guarantee shall not become effective until the Trustee or authenticating agent duly executes the certificate of authentication on this Security. This Guarantee shall be governed by and construed in
accordance with the laws of the State of New York, without regard to conflict of law principles thereof. 
 Dated: September [    ],
2022 
  

			
	MONDELĒZ INTERNATIONAL, INC.
		
	By:	 	              

		 	Name:
		 	Title:

  
 A-19Document

Exhibit 10.1

FORBEARANCE AGREEMENT 

This FORBEARANCE AGREEMENT, dated as of September 15, 2022 (this “Agreement”), is entered into by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), the Guarantors identified on the signature pages hereto (the “Guarantors” and, together with the Company being collectively referred to as the “Loan Parties”), the Purchasers party hereto (the “Consenting Purchasers”) and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity the “Designated Agent”), and is made with reference to the Securities Purchase and Security Agreement dated as of April 23, 2020 (the “Securities Purchase Agreement”) by and among the Company, the Guarantors , the purchasers from time to time party thereto (each, a “Purchaser”, and collectively, the “Purchasers”), and the Designated Agent.  
W I T N E S S E T H:
WHEREAS, (1) the Company has failed to make the interest payment in the amount of $683,069 due on March 31, 2022 and the interest payment in the amount of $707,926 due June 30, 2022 (including interest accruing on the March 31, 2022 installment, in each case, which shall be deemed to be paid in kind, as set forth in Section 6(b) below), pursuant to Section 3.2 of the Securities Purchase Agreement (the “Interest Payments”), which failures constitute immediate Events of Default pursuant to Section 9.1(a) of the Securities Purchase Agreement, (2) the Company has been delisted from the Nasdaq Stock Market as of August 11, 2022, which delisting constitutes an Event of Default pursuant to Section 8.1(d) of the Securities Purchase Agreement and (3) cross-default provisions of Other Note Agreements (as defined below) were potentially trigged by the Events of Default described above, thereby constituting an Event of Default pursuant to Section 9.1(c) of the Securities Purchase Agreement (collectively as set forth in Schedule I hereto the “Specified Defaults”);
WHEREAS, by virtue of the Specified Defaults, the Designated Agent has the right to accelerate payment of the Outstanding Balance per Section 9.2 of the Securities Purchase Agreement, absent the forbearance set forth in this Agreement;
WHEREAS, the Company has requested that the Designated Agent and the Purchasers agree to forbear during the Forbearance Period (as defined below) from exercising their rights and remedies as specified herein against the Company and the other Loan Parties with respect to the Specified Defaults; 
WHEREAS, the Company has requested that the Designated Agent and the Purchasers enter into the Ancillary Agreements (as defined below) for the benefit of the Loan Parties; 
WHEREAS, the Company has requested that the Purchasers consent to the incurrence of any additional indebtedness senior to that of the Purchasers by the Company following the Forbearance Effective Date (defined below) in an aggregate principal amount not to exceed $5,000,000 (the “Interim Financing”), subject to a right of first offer granted by the Company to the Purchasers, to provide the Interim Financing;
WHEREAS, the Company has requested that the Purchasers agree to negotiate a financial restructuring of the Company’s indebtedness and other obligations on a go-forward basis (a “Consensual Restructuring”), to be documented under a Restructuring Support Agreement (the “RSA”) by and among the Loan Parties, the Purchasers, the Designated Agent and other stakeholders;
WHEREAS, on the terms and subject to the conditions set forth herein, the undersigned Purchasers agree to enter into the Ancillary Agreements and to forbear from exercising their rights and remedies (and from directing the Designated Agent to exercise 

rights and remedies or otherwise take any enforcement action) against the Company and the other Loan Parties with respect to the Specified Defaults as specified herein.
NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:
SECTION 1.Definitions.  Each capitalized term used and not otherwise defined in this Agreement shall have the meaning assigned to such term in the Securities Purchase Agreement. As used in this Agreement, the following terms shall have the following meaning:
“2022 Purchase Agreements” shall mean (a) that certain Securities Purchase Agreement, dated January 13, 2022, by and among the Company and each of the investors listed on the schedule of buyers attached thereto and (b) that certain Securities Purchase Agreement, dated March 1, 2022, by and among the Company and each of the investors listed on the schedule of buyers attached thereto, in each case, as amended by the May Exchange Agreements (as defined below).
“Adjuvant Securities Purchase Agreement” shall mean that certain Securities Purchase Agreement, dated as of October 14, 2020, by and among the Company, Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund DE, L.P., as purchasers (the “Adjuvant Purchasers”), as amended by the First Amendment to Securities Purchase Agreement, entered into as of April 4, 2022, by and among the Company and each of the investors listed therein.
“Adjuvant Notes” shall mean the Notes (as defined in the Adjuvant Securities Purchase Agreement).
“May Exchange Agreements” shall mean the collective reference to each Amendment and May Exchange Agreement, dated as of May 4, 2022, by and between the Company and the investor signatories thereto and “May Exchange Agreement” means each such Amendment and Exchange Agreement, individually.
“Exchange Notes” shall mean the collective reference to each senior subordinated note issued by the Company pursuant to the applicable May Exchange Agreement.
 “Other Note Agreements” shall mean (a) the Adjuvant Securities Purchase Agreement, (b) the Adjuvant Notes, (c) the 2022 Purchase Agreements, (d) the May Exchange Agreements and (e) the May Exchange Notes.
SECTION 2.Ancillary Agreements. As of the date of this Agreement (the “Forbearance Effective Date”), the parties hereto shall execute and deliver: (i) that certain amendment to the Securities Purchase Agreement, in the form set forth on Exhibit A attached hereto (the “SPA Amendment”) and (ii) those certain Exchange Agreements in substantially the form attached hereto as Exhibit B and Exhibit C (the “September Exchange Agreements”, and together with the May Exchange Agreement and the SPA Amendment, the “Ancillary Agreements”).

SECTION 3.Confirmation by Company of Obligations and Specified Defaults.  
(a)The Company acknowledges and agrees that, as of the Forbearance Effective Date, the aggregate principal amount of the Outstanding Balance under the Securities Purchase Agreement (determined after giving effect to the capitalization of the Interest Payment and the Accrued Expenses (as defined below)) is $44,081,910.43, which amount includes the Additional Consideration and the PIK Coupon Payments (each, as defined below).  
2

(b)    The foregoing amount does not include interest payable in cash, fees, penalties, expenses and other amounts which are chargeable or otherwise reimbursable under the Securities Purchase Agreement and the other Transaction Documents, other than the Interest Payments and the Accrued Expenses as indicated above, and including costs and expenses that shall be added to the Outstanding Balance pursuant to Section 6(c) of this Agreement. Neither the Company nor the other Loan Parties have any rights of offset, defenses, claims or counterclaims with respect to any of the outstanding Secured Obligations.  
(c)    The Company acknowledges and agrees that each Specified Default constitutes an Event of Default. The Company represents and warrants that, except for the Specified Defaults, no other Event of Default has occurred and is continuing as of the Forbearance Effective Date.
SECTION 4.Consent.  Notwithstanding anything to the contrary set forth in the Securities Purchase Agreement or the other Transaction Documents, including, without limitation, Section 7.2(a) of the Securities Purchase Agreement, the Purchasers hereby consent to the incurrence by the Company and its subsidiaries of Interim Financing following the Forbearance Effective Date in an aggregate principal amount not to exceed $5,000,000. The Company will use reasonable best efforts to obtain Interim Financing through the offering and sale of equity securities and/or on an unsecured or junior secured basis.  In the event Interim Financing on commercially reasonable terms is available only on a senior secured basis, the Purchasers will agree to subordinate to such Interim Financing and waive any covenants or contractual prohibitions under the Securities Purchase Agreement and Transaction Documents proscribing the incurrence of such senior Indebtedness. Prior to entering into any Interim Financing, the Company shall provide the Purchasers with three (3) business days written notice of the terms of such Interim Financing, during which time the Purchasers shall have the right to extend Interim Financing on the same terms and condition of any other proposed third-party Interim Financing.  
SECTION 5.Agreement to Forbear.
(a)Effective as of the Forbearance Effective Date, each Consenting Purchaser (constituting all Purchasers under the Securities Purchase Agreement) agrees that until the expiration of the Forbearance Period, it will forbear from exercising its rights and remedies, and hereby instructs the Designated Agent to forbear from exercising rights and remedies and from otherwise taking any enforcement action, against the Company or any other Loan Party solely with respect to the Specified Defaults, including, but not limited to, the commencement of a lawsuit, exercising rights under any Account Control Agreements, and/or enforcement proceedings or other action against the Company and/or the other Loan Parties, in each case solely with respect to the Specified Defaults; provided, however, that (i) the Company and each other Loan Party shall comply with all limitations, restrictions or prohibitions that would otherwise be effective or applicable under the Securities Purchase Agreement or any of the other Transaction Documents upon the occurrence or during the continuance of any Event of Default, and (ii) nothing herein shall restrict, impair or otherwise affect any Purchaser’s rights and remedies (other than any such rights and remedies against the Loan Parties as and to the extent expressly set forth in this Agreement) under any agreements, including, without limitation, any agreement containing subordination provisions in favor of any or all of the Purchasers (including, without limitation, any rights or remedies available to the Purchasers as a result of the occurrence or continuation of any Specified Default) or amend or modify any provision thereof.  
As used herein, the term “Forbearance Period” shall mean the period from the Forbearance Effective Date to the date on which a Forbearance Termination Event first occurs, and the term “Forbearance Termination Event” shall mean the earliest of: 
(1)     the first date after December 31, 2022 on which the Company’s total cash falls below $1,000,000, 
3

(2)     the occurrence of any Event of Default, other than the Specified Defaults, 
(3)     the failure of any Loan Party to timely comply with any term or agreement set forth in this Agreement in any material respect, 
(4)     an acceleration by the requisite purchasers or investors, as applicable, under and in accordance with Other Note Agreements, as applicable, 
(5)     the date that the Company enters into any forbearance or similar agreement with the purchasers or investors, as applicable,  under any Other Note Agreement solely to the extent such forbearance or similar agreement requires the Company to make any payment to such purchasers or investors in cash (excluding, for the avoidance of doubt, (i) permitted payment of regularly scheduled principal and interest and reimbursement of fees and expenses in the ordinary course of business, (ii) the forbearance agreement entered into with Adjuvant on the date hereof and the Exchange Agreements), or
(6)    the date that the Company first challenges the validity or enforceability of the actions contemplated under this Agreement or the validity or enforceability of the rights of the Purchasers or the Designated Agent under the Securities Purchase Agreement (and the ancillary agreements thereunder) or the Warrants (defined below).  For the avoidance of doubt, the Secured Obligations are not impaired, reduced or affected by this Agreement and continue in full force and effect.
(b)Upon the expiration of the Forbearance Period, the agreement of the Purchasers hereunder to forbear from exercising their respective rights and remedies (and to cause the Designated Agent to forbear from exercising rights and remedies on behalf of the Purchasers) in respect of the Specified Defaults shall immediately terminate without the requirement of any demand, presentment, protest, or notice of any kind, all of which the Company and the other Loan Parties each waives.  The Company agrees that any or all of the Purchasers may at any time after the expiration of the Forbearance Period proceed to exercise any and all of their respective rights and remedies under any or all of the Securities Purchase Agreement, any other Transaction Document and/or applicable law, including, without limitation, their respective rights and remedies with respect to the Specified Defaults (including as set forth in Section 5.7(b) of the Securities Purchase Agreement).  Without limiting the generality of the foregoing, upon the expiration of the Forbearance Period, the Purchasers may, in their sole discretion and without the requirement of any demand, presentment, protest, or notice of any kind, (i) commence any legal or other action to collect any or all of the Secured Obligations from the Company, any other Loan Party or any Collateral, (ii) foreclose or otherwise realize on any or all of the Collateral and/or appropriate, setoff or apply to the payment of any or all of the Secured Obligations, any or all of the Collateral, and (iii) take any other enforcement action or otherwise exercise any or all rights and remedies provided for by any or all of the Securities Purchase Agreement, any other Transaction Documents and/or applicable law, all of which rights and remedies are fully reserved by the Purchasers.
(c)The Company acknowledges that the Purchasers have not made any assurances concerning (i) any possibility of an extension of the Forbearance Period, (ii) the manner in which or whether the Specified Defaults may be resolved or (iii) any additional forbearance, waiver, restructuring or other accommodation.
(d)In consideration of the agreements of the Designated Agent and the Consenting Purchasers to forbear as further set forth herein, (i) the Interest Payments shall be deemed to have been paid in kind and added to the Outstanding Balance as of each applicable payment date and (ii) $60,000 of out-of-pocket expenses of the Purchasers (the “Accrued Expenses”) shall be deemed to have been paid by adding the amount of such Accrued Expenses to the Outstanding Balance on the Forbearance Effective Date.
4

SECTION 6.Conditions to Agreement.  The agreement to forbear and the amendments set forth herein (including the effectiveness of the Ancillary Agreements) are subject to the satisfaction of each of the following conditions on or prior to the Forbearance Effective Date:
(a)the Designated Agent shall have received a counterpart signature page of this Agreement and the SPA Amendment, duly executed and delivered by the Company and each other Loan Party and Purchasers constituting all Purchasers under the Securities Purchase Agreement;
(b) the Company and the requisite parties thereto shall have entered into the Exchange Agreements; and 
(c)the Forbearance Agreement, dated September 15, 2022, by and among the Company, the guarantors thereto, the Adjuvant Purchasers, and the Designated Agent,  shall be duly executed by all parties.
SECTION 7.Adjustments to the Outstanding Balance. 
(a)In consideration for: (i) the agreement by the Purchasers to forbear during the Forbearance Period, and (ii) the entry into the Ancillary Agreements by the Purchasers and the resulting forfeiture of certain rights currently existing under the Securities Purchase Agreement and the Warrants, the principal amount of the Outstanding Balance for each Purchaser shall be increased by the corresponding amount set forth on Schedule II (the “Additional Consideration”).  The Company acknowledges and agrees that the Additional Consideration that is being added to the Outstanding Balance represents reasonably equivalent value to the Company, as defined by 11 U.S.C. § 548 and applicable state law. The Company hereby agrees to waive any claims against the Purchasers or the Designated Agent relating to or arising out of the transactions contemplated hereby (including any claims to avoid any part of the transactions as a fraudulent transfer under state or federal law).
(b) In lieu of the payment of the Interest Payments in cash, the Interest Payments shall be deemed paid in kind as of each applicable payment date (i.e., March 31, 2022 and June 30, 2022, respectively) and shall be added to the Outstanding Balance as of such payment due dates (the “PIK Coupon Payments”).  For the avoidance of doubt, the parties acknowledge and agree that interest payments under the Notes shall be paid in arrears on the last day of each calendar quarter ending on March 31, June 30, September 30 and December 31.
(c)Without duplication with the Accrued Expenses, the Company hereby acknowledges and agrees that the costs and expenses incurred by the Designated Agent and/or the Purchasers (including reasonable attorneys’ fees) relating to the Securities Purchase Agreement and their rights thereunder since the earliest occurrence of the Specified Defaults constitute “costs and expenses” for which the Designated Agent is entitled to repayment under Section 12.12 of the Securities Purchase Agreement.  Notwithstanding the Company’s obligations to reimburse such costs and expenses in cash, the parties hereto agree that such costs and expenses shall be deemed paid in kind and added to the Outstanding Balance upon presentation by the Designated Agent of invoices documenting such costs and expenses. During the Forbearance Period, expenses incurred by the Designated Agent in accordance with Section 12.12 of the Securities Purchase Agreement or in connection with this Agreement, the Ancillary Agreements and the transactions contemplated hereby and thereby, shall similarly be paid in kind and added to the Outstanding Balance upon presentation of invoices documenting such expenses.
SECTION 8.General Release; Indemnity.  In addition to, and not in lieu of or in any way limiting, the provisions of the Securities Purchase Agreement, in consideration of, among other things, the Designated Agent’s and Requisite Purchasers’ execution and delivery of this Agreement, each of the Company, on behalf of itself and its agents, representatives, officers, directors, advisors, employees, subsidiaries, affiliates, successors and assigns 
5

(collectively, “Releasors”), hereby forever agrees and covenants not to sue or prosecute against any Releasee (as hereinafter defined) and hereby forever waives, releases and discharges, to the fullest extent permitted by law, each Releasee (as hereinafter defined) from any and all claims (including, without limitation, crossclaims, counterclaims, rights of set-off and recoupment or claims of fraudulent transfer under state or federal law), actions, causes of action, suits, debts, accounts, interests, liens, promises, warranties, damages and consequential damages, demands, agreements, bonds, bills, specialties, covenants, controversies, variances, trespasses, judgments, executions, costs, expenses or claims whatsoever (collectively, the “Claims”), that such Releasor now has, of whatsoever nature and kind, whether known or unknown, whether arising at law or in equity, against any or all of the Purchasers (in their capacities as such) and their respective affiliates, subsidiaries, shareholders and “controlling persons” (within the meaning of the federal securities laws), and their respective successors and assigns and each and all of the officers, directors, employees, agents, attorneys and other representatives of each of the foregoing (collectively, the “Releasees”), solely to the extent based on facts, whether or not now known, existing on or before the Forbearance Effective Date, that relate to, arise out of or otherwise are in connection with:  (i) any or all of the Transaction Documents or transactions contemplated thereby or any actions or omissions in connection therewith or (ii) any aspect of the dealings or relationships between or among the Company and the other Loan Parties, on the one hand, and any or all of the Purchasers, on the other hand, relating to any or all of the documents, transactions, actions or omissions referenced in clause (i) hereof. In entering into this Agreement, the Company consulted with, and has been represented by, legal counsel and expressly disclaims any reliance on any representations, acts or omissions by any of the Releasees and hereby agrees and acknowledges that the validity and effectiveness of the releases set forth above do not depend in any way on any such representations, acts and/or omissions or the accuracy, completeness or validity hereof.  Notwithstanding the foregoing, the directors and officers of the Company do not waive and may assert any defenses they may have as of the date hereof in connection with any claims made against them related to the foregoing. The provisions of this Section 5 shall survive the termination of this Agreement, the Securities Purchase Agreement, the other Transaction Documents and payment in full of the Secured Obligations. Notwithstanding anything to the contrary herein, the rights of the Company’s officers and directors to receive indemnification from the Company pursuant to applicable law and agreements by and between the Company and such persons shall not be altered or otherwise affected pursuant to the terms of this Agreement. 

(a)The Company hereby agrees that it shall be obligated to indemnify and hold the Releasees harmless with respect to any and all liabilities, obligations, losses, penalties, actions, judgments, suits, costs, expenses or disbursements which are direct, indirect or consequential in nature which are incurred by the Releasees, or any of them as a result of or arising from or relating to any proceeding by, or on behalf of any Person, including, without limitation, the respective officers, directors, agents, trustees, creditors, partners or shareholders of the Company, any other Loan Party, or any of their respective Subsidiaries, whether threatened or initiated, in respect of any claim for legal or equitable remedy under any statue, regulation or common law principle arising from or in connection with the negotiation, preparation, execution, delivery, performance, administration and enforcement of the Securities Purchase Agreement, the other Transaction Documents, this Agreement or any other document executed and/or delivered in connection herewith; provided, that neither the Company nor any other Loan Party shall have any obligation to indemnify or hold harmless any Releasee hereunder with respect to liabilities to the extent they result from the gross negligence or willful misconduct of that Releasee as finally determined by a court of competent jurisdiction.  If and to the extent that the foregoing undertaking may be unenforceable for any reason, the Company agrees to make the maximum contribution to the payment and satisfaction thereof which is permissible under applicable law.  The foregoing indemnity shall survive the termination of this Agreement, the Securities Purchase Agreement, the other Transaction Documents and the payment in full of the Secured Obligations.
6

(b)The Company, on behalf of itself and its successors and assigns, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Releasee on the basis of any Claim released, remised and discharged by the Company or any other Loan Party pursuant to this Section 5.  If the Company or any of its successors or assigns violates the foregoing covenant, the Company, for itself and its successors and assigns, agrees to pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys’ fees and costs incurred by any Releasee as a result of such violation.
SECTION 9.Representations and Warranties.  Each Loan Party hereby represents and warrants to the Designated Agent and each Purchaser (in each case solely with respect to itself), in each case as of the Forbearance Effective Date, that:
(a)Such Loan Party has the requisite power and authority, and the legal right, to enter into this Agreement.  Such Loan Party has taken all necessary corporate or other organizational action to authorize the execution, delivery and performance of this Agreement.  This Agreement constitutes a legal, valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law).
(b)The representations and warranties made by such Loan Party pursuant to Section 5 of the Securities Purchase Agreement are true and correct in all material respects on and as of the Forbearance Effective Date, after giving effect to this Agreement and with the exception, where applicable, of the Specified Defaults, as if made on and as of such date except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties were true and correct in all material respects on and as of such earlier date.
(c)Immediately after giving effect to this Agreement and the Ancillary Agreements, except for the Specified Defaults, no Event of Default shall be continuing on and as of the Forbearance Effective Date or will result from the consummation of the transactions contemplated by this Agreement.
SECTION 10.Entire Agreement.  This Agreement (including the exhibits attached hereto), the Securities Purchase Agreement and the other Transaction Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof.  No amendment of any of the foregoing documents shall be valid unless memorialized in a writing by the Purchasers and the Designated Agent.
SECTION 11.GOVERNING LAW.  THIS AGREEMENT, AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT, AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON OR ARISING OUT OF THIS AGREEMENT OR THE SECURITIES PURCHASE AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.
SECTION 12.Consent to Jurisdiction; Waiver of Jury Trial.  The jurisdiction and waiver of jury trial provisions set forth in Sections 12.3 of the Securities Purchase Agreement are hereby incorporated by reference, mutatis mutandis.
7

SECTION 13.Consent to Service of Process.  Each party to this Agreement irrevocably consents to the service of process in the manner provided for notices in Section 12.7 of the Securities Purchase Agreement.  Nothing in any Transaction Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.
SECTION 14.Severability.  Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable.
SECTION 15.Transaction Document.  This Agreement constitutes a “Transaction Document” for all purposes of the Securities Purchase Agreement and the other Transaction Documents.
SECTION 16.Reaffirmation.  Each of the undersigned Loan Parties (a) acknowledges all of its obligations, undertakings and liabilities under the Securities Purchase Agreement and the other Transaction Documents to which it is a party in each case as amended in connection herewith and such obligations, undertakings and liabilities, where applicable, are hereby reaffirmed and remain in full force and effect on a continuous basis and (b) agrees that its grant of security interests pursuant to the Security Agreement is reaffirmed and remains in full force and effect after giving effect to this Agreement and secures all Secured Obligations (as in effect after giving effect hereto).
SECTION 17.Counterparts.  This Agreement may be executed by the parties hereto in any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by fax, email or other electronic transmission (including in .pdf or .tif format) shall be effective as delivery of a manually executed counterpart of this Agreement.
SECTION 18.Headings.  The headings of this Agreement are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.
SECTION 19.Effect of this Agreement.  Except as expressly set forth in this Agreement, this Agreement (a) shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Purchasers or the Designated Agent, in each case under the Securities Purchase Agreement or any other Transaction Document, and (b) shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Securities Purchase Agreement or any other Transaction Document. Except as expressly set forth in this Agreement, each and every term, condition, obligation, covenant and agreement contained in the Transaction Documents is hereby ratified and reaffirmed in all respects and shall continue in full force and effect. The execution, delivery and effectiveness of this Agreement shall not, except as expressly provided in this Agreement, operate as a waiver of any right, power or remedy of any Purchaser or the Designated Agent under any of the Transaction Documents, or constitute a waiver of any provision of any of the Transaction Documents. This Agreement shall not extinguish the obligations for the payment of money outstanding under the Securities Purchase Agreement. Nothing herein contained shall be construed as a substitution or novation of the obligations outstanding under the Securities Purchase Agreement, which shall remain in full force and effect, except to any extent amended or modified by this Agreement.  Nothing implied in this Agreement shall be construed as a release or other discharge any of the Loan Parties from the Transaction Documents. From and after the Forbearance Effective Date, all references to the Securities Purchase Agreement in any Transaction Document and all references in the Securities Purchase Agreement to “this 
8

Agreement,” “hereunder,” “hereof” or words of like import referring to the Securities Purchase Agreement shall, unless expressly provided otherwise, be deemed to refer to the Securities Purchase Agreement, as modified by this Agreement.  Each of the Loan Parties hereby consents to this Agreement and confirms that all obligations such Loan Party under the Transaction Documents to which the Company is a party shall continue to apply to the Securities Purchase Agreement, as modified by this Agreement.
SECTION 20.Successors and Assigns.  This Agreement shall inure to the benefit of and be binding upon each of the parties hereto, each Purchaser and the successors and permitted assigns of each of the parties hereto and each Purchaser.    
[Signature Pages Follow]
9

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their respective duly authorized officers as of the day and year first above written.
																		
		COMPANY:
						
		EVOFEM BIOSCIENCES, INC.
						
		By:	/s/ Justin J. File
		
		Name:  Justin J. File
		
		Title:  Chief Financial Officer
		
						
		GUARANTORS:
		
		EVOFEM, INC.
EVOFEM BIOSCIENCES OPERATIONS, INC.
EVOFEM LIMITED, LLC
EVOFEM NORTH AMERICA, INC.

						
						
		By:	/s/ Justin J. File
		
		Name:  Justin J. File
		
		Title:  Chief Financial Officer
		

    Forbearance Agreement

																		
		BAKER BROS. ADVISORS LP, as Designated Agent
						
		By:	/s/ Scott Lessing		
			Scott Lessing
		
			President

Forbearance Agreement

																		
		667, L.P., as a Purchaser 
						
		By: Baker Bros. Advisors LP, management company and investment adviser to 667, L.P., pursuant to authority granted to it by Baker Biotech Capital, L.P., general partner  to 667, L.P., and not as the general partner. 

						
		By:	/s/ Scott Lessing		
			Scott Lessing
		
			President

																		
		BAKER BROTHERS LIFE SCIENCES, L.P., as a Purchaser

						
		By:  BAKER BROS. ADVISORS LP,  management company and investment adviser to Baker Brothers Life Sciences, L.P., pursuant to authority granted to it by Baker Brothers Life Sciences Capital, L.P., general partner to Baker Brothers Life Sciences, L.P., and not as the general partner. 

						
		By:	/s/ Scott Lessing		
			Scott Lessing
		
			President

    Forbearance Agreement

Exhibit A

SPA Amendment

    Forbearance Agreement

Exhibit B

Adjuvant Exchange Agreement

    Forbearance Agreement

Exhibit C

Exchange Agreement
    Forbearance Agreement

Schedule I

SPECIFIED DEFAULTS

Any default or Event of Default related to the failure to remit the interest payment in the amount of $683,069 due on March 31, 2022 and the interest payment in the amount of $707,926 due on June 30, 2022, including pursuant to §§ 9.1(a) and (c) of the Securities Purchase Agreement.
Any default or Event of Default related to the suspension of trading of shares of the Company’s Common Stock on the Nasdaq Capital Market and any potential delisting of the Company’s Common Stock from the Nasdaq Capital Market as of August 11, 2022, including pursuant to §§ 8.1(d), 9.1(c) and (e) of the Securities Purchase Agreement.

    Forbearance Agreement

Schedule II

667, L.P.: $1,234,527.57
Baker Brothers Life Sciences, L.P.: $13,459,442.57

    Forbearance Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]